AGP Picks
View all

Nebraska Tech Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nebraska Tech Daily.

Press releases published on May 7, 2026

BOSS Zhipin's Ongoing Share Repurchases Reach Nearly RMB100 Million in May 2026
Telesur joins forces with EllaLink on its new Caribbean Gateway project
Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights
Real Messenger Announces It Has Regained Compliance with Nasdaq Minimum Bid Price Requirement
LIfT Biosciences Establishes Scientific Advisory Board to Accelerate Development of Neutrophil-based Cancer Therapies
Accumulus Technologies Announces Live Integration with Veeva RIM, Enabling Seamless RIM to Regulator Connection
Gyre Therapeutics Reports First Quarter 2026 Results and Provides Business Update
GigaCloud Technology Inc Announces First Quarter Ended March 31, 2026 Financial Results
ESET Research uncovers CallPhantom scam on Google Play: Fake logs for real money
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
Other World Computing (OWC) Expands UK Channel with M2M Direct Distribution Partnership
Scarlet Therapeutics Demonstrates In Vivo Survival of Lab-Grown Universal Red Blood Cells Equivalent to Donated Blood
ViaNautis Bio to present its targeted polyNaut® nanovesicles (tPNVs) for the generation of in vivo CAR-T therapies at ASGCT Annual Meeting
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
LinkedIn partners with the Digital Vending Machine® from Bango to expand Premium reach through bundling
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
Zealand Pharma - Execution framework for share buy-back program
Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders
Zealand Pharma Announces Financial Results for the First Three Months of 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Nebraska Tech Daily

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.